Christopher W Towe1, Sudershan Srinivasan2, Vanessa P Ho3, Katelynn Bachmann2, Stephanie G Worrell2, Yaron Perry4, Luis M Argote-Green2, Philip A Linden2. 1. Division of Thoracic and Esophageal Surgery, Department of Surgery, University Hospitals Cleveland Medical Center and Case Western Reserve School of Medicine, Cleveland, Ohio. Electronic address: christopher.towe@uhhospitals.org. 2. Division of Thoracic and Esophageal Surgery, Department of Surgery, University Hospitals Cleveland Medical Center and Case Western Reserve School of Medicine, Cleveland, Ohio. 3. Division of Trauma, Critical Care, Burns, and Emergency General Surgery, MetroHealth Medical Center and Case Western Reserve School of Medicine, Cleveland, Ohio. 4. University of Buffalo School of Medicine, Buffalo, New York.
Abstract
BACKGROUND: Previous studies of decortication for empyema demonstrated that patient characteristics are associated with mortality, but the relationship of infectious pathogen to outcome has not been described. Our objective was to analyze the association of microbiology and antibiotic resistance with postoperative mortality after decortication for empyema. We hypothesized that bacterial pathogens, antibiotic resistance, and patient characteristics would all contribute to perioperative morbidity and mortality. METHODS: Patients undergoing pulmonary decortication for empyema from January 1, 2010 to October 1, 2017 were reviewed retrospectively. Cases were matched with microbiology cultures. Outcomes of interest were a composite of death, tracheostomy, initial ventilator support greater than 48 hours, or unexpected intensive care unit readmission. Antibiotic resistance was categorized as present or absent, and the number of antibiotics with resistance was counted for each patient. We describe the relationship of patient characteristics, antibiotic resistance, and microbiology to mortality. RESULTS: During the study period, 185 patients underwent decortication, 118 of whom had a diagnosis of primary empyema (63.8%). Positive culture results were present in 79 of 185 patients (43%). The most common isolate was Streptococcus, which was present in 29 of 79 (37%), followed by Staphylococcus in 19 of 79 (24%). Of 79 patients, 11 had fungal infections (13.9%). In addition, 16 of 79 patients had polymicrobial empyema (20%). Of 185 patients, 30 experienced the composite adverse outcome (16.2%). In multivariable regression, the composite adverse outcome was associated with emphysema, Candida in pleural culture, and antibiotic resistance count. CONCLUSIONS: Perioperative mortality and morbidity after decortication for empyema is considerable. In this cohort, infections with increasing antibiotic resistance are associated with morbidity and mortality among patients with empyema.
BACKGROUND: Previous studies of decortication for empyema demonstrated that patient characteristics are associated with mortality, but the relationship of infectious pathogen to outcome has not been described. Our objective was to analyze the association of microbiology and antibiotic resistance with postoperative mortality after decortication for empyema. We hypothesized that bacterial pathogens, antibiotic resistance, and patient characteristics would all contribute to perioperative morbidity and mortality. METHODS: Patients undergoing pulmonary decortication for empyema from January 1, 2010 to October 1, 2017 were reviewed retrospectively. Cases were matched with microbiology cultures. Outcomes of interest were a composite of death, tracheostomy, initial ventilator support greater than 48 hours, or unexpected intensive care unit readmission. Antibiotic resistance was categorized as present or absent, and the number of antibiotics with resistance was counted for each patient. We describe the relationship of patient characteristics, antibiotic resistance, and microbiology to mortality. RESULTS: During the study period, 185 patients underwent decortication, 118 of whom had a diagnosis of primary empyema (63.8%). Positive culture results were present in 79 of 185 patients (43%). The most common isolate was Streptococcus, which was present in 29 of 79 (37%), followed by Staphylococcus in 19 of 79 (24%). Of 79 patients, 11 had fungal infections (13.9%). In addition, 16 of 79 patients had polymicrobial empyema (20%). Of 185 patients, 30 experienced the composite adverse outcome (16.2%). In multivariable regression, the composite adverse outcome was associated with emphysema, Candida in pleural culture, and antibiotic resistance count. CONCLUSIONS: Perioperative mortality and morbidity after decortication for empyema is considerable. In this cohort, infections with increasing antibiotic resistance are associated with morbidity and mortality among patients with empyema.
Authors: John E Mazuski; Jeffrey M Tessier; Addison K May; Robert G Sawyer; Evan P Nadler; Matthew R Rosengart; Phillip K Chang; Patrick J O'Neill; Kevin P Mollen; Jared M Huston; Jose J Diaz; Jose M Prince Journal: Surg Infect (Larchmt) Date: 2017-01 Impact factor: 2.150
Authors: K Robert Shen; Alejandro Bribriesco; Traves Crabtree; Chad Denlinger; Joshua Eby; Patrick Eiken; David R Jones; Shaf Keshavjee; Fabien Maldonado; Subroto Paul; Benjamin Kozower Journal: J Thorac Cardiovasc Surg Date: 2017-02-04 Impact factor: 5.209
Authors: Tara R Semenkovich; Margaret A Olsen; Varun Puri; Bryan F Meyers; Benjamin D Kozower Journal: Ann Thorac Surg Date: 2018-03-14 Impact factor: 4.330